Safety and Efficacy of Faricimab in Patients With NPDR

Clinical trial NCT05681884 · COMPLETED

Trial details

NCT number: NCT05681884
Sponsor: Greater Houston Retina Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Proliferative Diabetic Retinopathy

Start date: 2023-05-16
Primary completion: 2026-02-26
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.